Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the ...

Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

The conversation surrounding health care reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health ...

Scientists have discovered a potential new treatment for familial hypercholesterolemia, inspired by signs seen in the Mona ...

The AHA's 2025 report highlights alarming trends in cardiovascular disease, obesity, and lifestyle factors, emphasizing the ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

He was suddenly, fully awake from a sound sleep at 1 a.m., the Saturday of Labor Day weekend. Something was seriously wrong. He felt as if his upper torso was encased in a band, tight and growing ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...